Literature DB >> 22082718

The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.

Ank E Nijhawan1, Alison K DeLong, David D Celentano, Robert S Klein, Jack D Sobel, Denise J Jamieson, Susan Cu-Uvin.   

Abstract

BACKGROUND: The prevalence of Trichomonas vaginalis is higher among incarcerated women than in the general community. We sought to determine whether a history of incarceration itself was independently associated with trichomoniasis.
METHODS: The HIV Epidemiology Research Study is a prospective cohort study of 871 HIV-seropositive and 439 high-risk seronegative women in 4 urban centers (Bronx, NY; Detroit, MI; Providence, RI; Baltimore, MD). All participants enrolled between April 1993 and January 1995, with interviews and physical examinations conducted at baseline and at follow-up visits every 6 months up to 7 years.
RESULTS: Of 1310 subjects, 427 (33%) reported being incarcerated on at least one occasion. In addition, 724 (55%) were found to have a sexually transmitted infection on at least one occasion during the study; baseline rates were 21% for T. vaginalis, 4.3% for Chlamydia trachomatis, 0.6% for N. gonorrhea, and 8% for syphilis. Incarceration was associated with the detection of trichomonas infection (between-subject, odds ratio, 2.4; 95% confidence interval: 1.85-3.14; P < 0.01 and within-subject, odds ratio, 1.56; 95% confidence interval: 1.26-1.92; P < 0.01). The association with incarceration remained significant after adjusting for age, race, HIV status, enrollment risk group, number of sexual partners, marital status, education, bacterial vaginosis, vaginal candidiasis, drug use (crack, cocaine, heroin), alcohol use, health insurance, receipt of public assistance, employment status, visit number, and study site.
CONCLUSIONS: A history of incarceration was independently associated with the detection of trichomonas infection in a cohort of high-risk women. These data have implications for increased sexually transmitted infection prevention, screening, and treatment upon entry to jail as well as in the communities most affected by incarceration.

Entities:  

Mesh:

Year:  2011        PMID: 22082718      PMCID: PMC3767476          DOI: 10.1097/OLQ.0b013e31822ea147

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  41 in total

1.  Concurrent sexual partnerships among women in the United States.

Authors:  Adaora A Adimora; Victor J Schoenbach; Dana M Bonas; Francis E A Martinson; Kathryn H Donaldson; Tonya R Stancil
Journal:  Epidemiology       Date:  2002-05       Impact factor: 4.822

2.  Sexually transmitted diseases and tubal pregnancy.

Authors:  K J Sherman; J R Daling; A Stergachis; N S Weiss; H M Foy; S P Wang; J T Grayston
Journal:  Sex Transm Dis       Date:  1990 Jul-Sep       Impact factor: 2.830

3.  Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection.

Authors:  Susan Cu-Uvin; Hyejin Ko; Denise J Jamieson; Joseph W Hogan; Paula Schuman; Jean Anderson; Robert S Klein
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

4.  Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; Jack Moodley; A Willem Sturm
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

5.  Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.

Authors:  Alexis M Roth; James A Williams; Ryan Ly; Karen Curd; Dan Brooks; Janet Arno; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2011-05       Impact factor: 2.830

6.  Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.

Authors:  L F Lawing; S R Hedges; J R Schwebke
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection.

Authors:  Adaora A Adimora; Victor J Schoenbach; Francis E A Martinson; Kathryn H Donaldson; Tonya R Stancil; Robert E Fullilove
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-01       Impact factor: 3.731

8.  Concurrent sexual partnerships among African Americans in the rural south.

Authors:  Adaora A Adimora; Victor J Schoenbach; Francis Martinson; Kathryn H Donaldson; Tonya R Stancil; Robert E Fullilove
Journal:  Ann Epidemiol       Date:  2004-03       Impact factor: 3.797

9.  Double-stranded RNA viral infection of Trichomonas vaginalis infecting patients attending a sexually transmitted diseases clinic.

Authors:  Karen A Wendel; Anne M Rompalo; Emily J Erbelding; T-H Chang; John F Alderete
Journal:  J Infect Dis       Date:  2002-07-19       Impact factor: 5.226

10.  What is moderate drinking? Defining "drinks" and drinking levels.

Authors:  M C Dufour
Journal:  Alcohol Res Health       Date:  1999
View more
  10 in total

1.  Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.

Authors:  Alissa Davis; Anindita Dasgupta; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Infectious Diseases and the Criminal Justice System.

Authors:  Ank E Nijhawan
Journal:  Am J Med Sci       Date:  2016-05-27       Impact factor: 2.378

4.  Self-Reported Sexually Transmitted Infections After Incarceration in Women with or at Risk for HIV in the United States, 2007-2017.

Authors:  Andrea K Knittel; Jacqueline E Rudolph; Bonnie E Shook-Sa; Andrew Edmonds; Catalina Ramirez; Mardge Cohen; Tonya Taylor; Adebola Adedimeji; Katherine G Michel; Joel Milam; Jennifer Cohen; Jessica D Donohue; Antonina Foster; Margaret A Fischl; Dustin M Long; Adaora A Adimora
Journal:  J Womens Health (Larchmt)       Date:  2021-12-30       Impact factor: 3.017

Review 5.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

6.  Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States.

Authors:  Irene Kuo; Carol E Golin; Jing Wang; Danielle F Haley; James Hughes; Sharon Mannheimer; Jessica Justman; Anne Rompalo; Paula M Frew; Adaora A Adimora; Lydia Soto-Torres; Sally Hodder
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

7.  Correlates of Trichomonas vaginalis Among Middle Age and Older Adults Who Use Drugs.

Authors:  Lauren E Hearn; Nicole Ennis Whitehead; Eugene M Dunne; William W Latimer
Journal:  Subst Use Misuse       Date:  2015-11-19       Impact factor: 2.164

8.  Prevalence and factors associated with Trichomonas vaginalis infection among high-risk women in Los Angeles.

Authors:  Marjan Javanbakht; Ali Stirland; Shauna Stahlman; Lisa V Smith; Michael Chien; Ruel Torres; Sarah Guerry
Journal:  Sex Transm Dis       Date:  2013-10       Impact factor: 2.830

9.  Prevalence and predictors of trichomonas infection in newly incarcerated women.

Authors:  Ank E Nijhawan; Kimberle C Chapin; Rachel Salloway; Sarah Andrea; Jessi Champion; Mary Roberts; Jennifer G Clarke
Journal:  Sex Transm Dis       Date:  2012-12       Impact factor: 2.830

10.  Bacterial Vaginosis and Its Association With Incident Trichomonas vaginalis Infections: A Systematic Review and Meta-Analysis.

Authors:  Arlene C Seña; Linda A Goldstein; Gilbert Ramirez; Austin J Parish; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.